This case report describes the effects of glossopharyngeal breathing on respiration and speech in a patient with tetraplegia due to multiple sclerosis. Glossopharyngeal breathing is a technique where air is insufflated with the glossopharyngeal muscles, to increase vital capacity. Results from follow-up assessments up to 20 months after intervention showed that (1) the patient's speech and respiratory function with glossopharyngeal breathing improved over time, (2) the patient's respiratory function without glossopharyngeal breathing deteriorated over time (possibly because of a severe cold), and (3) at each assessment, the patient's speech and respiratory function was better with glossopharyngeal breathing than without it.
Introduction
Neuromuscular disease affecting respiratory musculature may lead to dyspnoea, difficulty mobilizing pulmonary secretions, vocal instability, reduced vocal loudness, and short speech phrases. 1, 2 When inspiratory musculature is weak, glossopharyngeal breathing (or 'glossopharyngeal pistoning for lung insufflation, GI) can be used to increase vital capacity (VC). 3, 4 Small amounts of air are gulped into the lungs with the glossopharyngeal muscles to stretch the rib cage, resulting in increased VC and improved ventilation. With increased VC, expiratory relaxation pressure also increases, which can be used to improve voice and speech. 2, 5 
Case report
The patient was a 47-year-old male with chronic progressive multiple sclerosis (MS) (EDSS 9.0) and complete tetraplegia with a slightly increased tonus. Bulbar function was not impaired. The patient's respiratory musculature was weak, the abdominal wall protruding due to diaphragm and abdominal wall weakness. Respiratory muscle strength, lung volumes and capacities were reduced. Although the respiratory function was extremely reduced, there were no signs of difficulty for either coordinating respiratory movements for breathing or coordinating respiration and laryngeal function for voice production. He used accessory muscles for breathing, spoke in short phrases with reduced loudness and was sometimes completely aphonic, which affected speech intelligibility negatively. The patient was not able to voluntarily take deeper breaths or to increase voice intensity. With air passively insufflated by an Ambu bag, the patient's VC increased, as did vocal stability, voice intensity and duration of sustained vowel ('a'). Hence GI was suggested as a first-choice intervention with the aim of increasing his VC, vocal loudness and speech duration. The study was approved of by the Regional Ethical Committee, Stockholm, DNR 2009/565-31.
Procedures and materials

Intervention
The patient received instructions from a physiotherapist and then practised independently, performing 3 × 3 GI-sessions 3 days a week. For each GI-session he was instructed to gulp as much air as possible, as long as he did not experience any discomfort. 3, 4 The patient learned the GI technique easily. When performing sessions with GI, he typically stacked 11-14 gulps.
Assessments
A single subject study design with repeated measurements was used. Respiratory function, cough and speech were assessed three times prior to the intervention period (IP), twice during the 7-week IP, twice after the IP and at follow-up 6, 12 and 20 months post-intervention (FU 6 , FU 12 and FU 20 ). Post IP the patient answered questions regarding his experience of the intervention and its effects on his speech and his situation.
Speech samples were recorded using the Phog software (Saven Hitech AB) and a head-mounted electret microphone (Sennheiser MKE2) at 15 cm distance from the lips. Lung function was measured with a portable spirometer (Micro Loop; Micro Medical). 6 The acoustic analyses were done in the Soundswell®™ software. 7 Both practical circumstances and the patient's daily health status (pulmonary secretions, fatigue) restricted his ability to participate and some sessions were cancelled, which is why data are not complete from all assessments.
Outcome measures
Data include the best performances from pre-IP, IP, post-IP plus the performances at the follow-up assessments. Speech outcome measures were maximum phonation time (MPT) in seconds (s) for a sustained vowel 'a', utterance duration in seconds and utterance length in number of syllables/breath when counting days, and vocal loudness in mean sound pressure level (SPL) in decibels (dB). Respiratory outcome measures were forced vital capacity (FVC) in litres/second and peak cough flow (PCF) in litres/minute. Except for pre-IP, assessments included performing all tasks with GI.
Results
Without GI, all but one speech outcome measure, viz. SPL for a sustained 'a', were improved at FU 20 compared with during the IP (Table 1, Figure 1 ). At FU 20 utterance duration without GI was 200% longer and utterance length 350% longer than during the IP. FVC and PCF without GI decreased markedly during the IP and continued to decrease up to FU 6 . At worst, FVC was 37% and PCF 30% below the performance pre-IP (see black arrows in Figure 1 ).
The patient expressed that GI had improved his situation: he could make himself heard again, specifically over the telephone. He also continued to use GI when he felt he needed to after the IP.
Discussion
Three findings are particularly evident: (1) the patient's speech and respiratory function with GI improves over time, (2) the patient's respiratory function without GI deteriorates over time, and (3) at each assessment, the patient's speech and respiratory function are better with GI than without GI.
Despite the positive objective and subjective effects, improved FVC due to the stretching of the rib cage was not found. 3 Instead, both respiratory and speech data reflected a temporary exacerbation during the IP (FVC −33% and MPD −25%, Figure 1) , possibly due to a severe cold. The data also indicate that an individual with severely restricted respiration may suffer from long-lasting negative effects on respiration and speech after a cold.
The deterioration in respiration and speech might also have been caused by MS-related fatigue or a progression in the MS. However, the fact that the patient was able to improve his performance with GI, which demands increased effort, contradicts this. Neither is a progression of the patient's primary progressive MS a probable explanation, since data for the performances without GI showed a slow recovery over time.
To incorporate GI into running speech takes both effort and training. Timing of the frequent pauses for gulping is needed. Planning is required to decide the number of gulps needed to stretch the rib cage enough for a specific speech task. GI can easily be practised independently, but optimizing speech with GI may require professional support.
Conclusions
In individuals with limited respiratory support, as for example in severe MS, GI may be considered to optimize voice and speech function. In this patient GI seemed to help maintaining respiratory and speech function during temporary respiratory exacerbation following a cold. This is a finding that would be of interest to study further.
